Search
for
Sort by
Research 181–210 of 1000+
- Alopecia Areata: The Clinician and Patient Voice
- A case study of homoeopathic treatment for alopecia areata
- ¿Qué esconde la alopecia? Alopecia universalis como síntoma de inicio de un paciente seropositivo al VIH
- Frontal Fibrosing Alopecia – a review and a practical guide for clinicians
- Epidemiologie und Pathogenese des Lichen planopilaris in der Hautklinik der Charité Berlin
- Clinical analysis of 83 cases of severe alopecia areata
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Vogt-Koyanagi-Harada Disease with Oral Manifestations: A Rare Case Report
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Vitamin D and Alopecia Areata: From Mechanism to Therapeutic Implications
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Alopecia areata: recognition, diagnosis and management
- New treatment modalities of alopecia areata
- Possible Integrative Approaches to Treatment of Alopecia: A Case Study Provides a Protocol Approach
- Alopecia areata, actualización clínica y terapéutica
- Targetoid Hair Regrowth Pattern in Alopecia Areata: A Case Series
- ALOPECIA AND ITS AYURVEDIC MANAGEMENT: A CASE REPORT
- The pharmacological treatment of alopecia areata
- SHAREABLE RESOURCE
- Alopecia areata: a review of disease pathogenesis
- Italian Guidelines in diagnosis and treatment of alopecia areata
- Alopecia areata but not androgenetic alopecia is characterized by a restricted and oligoclonal T-cell receptor-repertoire among infiltrating lymphocytes
- Association of Sensorineural Hearing Loss in Patients With Alopecia Areata
- Mechanisms of tolerance and potential therapeutic interventions in Alopecia Areata
- Alopecia areata. How not to miss Satoyoshi syndrome?
- Antinuclear and Antithyroid Antibodies in 68 Japanese Patients with Alopecia areata
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- Unusual acute lupus hemophagocytic syndrome – a test of diagnostic criteria: a case report
- Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata